Showing results (181-190 of 436) with videos related to
Sort By:
Pageof 44
British Journal of Haematology|February 13, 2003
Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimenChristopher L Morris, Eric Siegel, Bart Barlogie, et al.Bioinformatics (Oxford, England)|February 16, 2002
CGO: utilizing and integrating gene expression microarray data in clinical research and data managementKlaus Bumm, Mingzhong Zheng, Clyde Bailey, et al.Oncology Nursing Forum|May 10, 2008
Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myelomaElizabeth A Coleman, Sharon K Coon, Robert L Kennedy, et al.Oncotarget|June 21, 2014
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosisXenofon Papanikolaou, Sarah Johnson, Tarun Garg, et al.Haematologica|July 5, 2006
Clinical and biological features of multiple myeloma involving the gastrointestinal systemGiampaolo Talamo, Federica Cavallo, Maurizio Zangari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2009
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204)Mohamad A Hussein, Vanessa Bolejack, Jeffrey A Zonder, et al.Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.Journal of the American College of Emergency Physicians Open|July 7, 2022
Digital nerve blocks: A systematic review and meta-analysisTiffany Y Borbón, Pingping Qu, T Tausala Coleman-Satterfield, et al.Clinical Advances in Hematology & Oncology : H&O|December 5, 2017
The effect of novel therapies in high-molecular-risk multiple myelomaGuido Lancman, Douglas Tremblay, Kevin Barley, et al.Blood Advances|June 28, 2018
Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modelingVernon Wu, Erin Moshier, Siyang Leng, et al.Pageof 44